Chemistry: physical processes – Physical processes – Crystallization
Patent
1981-04-14
1982-12-07
Marantz, Sidney
Chemistry: physical processes
Physical processes
Crystallization
23915, 252408, 424 1, 424 12, G01N 3354, G01N 3378
Patent
active
043625312
ABSTRACT:
In particle agglutination immunoassays for an analyte (e.g. an antigen or antibody) in a liquid sample (e.g. human serum), interferences arise due to non-specific protein-protein interactions and the like. These interferences are reduced or overcome by including in the assay mixture a chaotropic or chaotropic-like agent, in a carefully controlled amount. Such agents include guanidine, guanidinium hydrochloride or thiocyanate, sodium or ammonium thiocyanate, and urea, sodium chloride and ethylenediamine tetraacetic acid.
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs
patent: 4200436 (1980-04-01), Mochido
patent: 4292038 (1981-09-01), Kondo
patent: 4298593 (1981-11-01), Ling
patent: 4299815 (1981-11-01), Hansen
patent: 4305925 (1981-12-01), Kapmeyer
H. L. Vader et al., Clinica Chimica Acta, 80, 361-372, (1977).
Chemical Abstracts, 90:20740c, (1979).
Collet-Cassart Daniel
de Steenwinkel Floris
Masson Pierre L.
Herron Charles J.
Marantz Sidney
Technicon Instruments Corporation
Tedesco S. P.
LandOfFree
Agglutination immunoassays carried out with agent to reduce non- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agglutination immunoassays carried out with agent to reduce non-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agglutination immunoassays carried out with agent to reduce non- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1901238